Dendritic cells derived from peripheral blood monocytes of patients with malignant tumor:a study of in vitro activity and function

ZHU Yi-bei,ZHANG Xue-guang,HUANG Yong,CHEN Cheng,LI Wen-xiang,DAI Jun,XIA Yu,WU Ming-yuan
DOI: https://doi.org/10.3872/j.issn.1007-385X.2007.03.013
2007-01-01
Abstract:Objective:To investigate the expression of costimulatory molecules of dendritic cells derived from monocytes obtained from the peripheral blood of patients with malignant tumor and their functions.Methods:Peripheral blood samples were obtained from 11 patients with lung cancer,ovarian cancer,or gastric cancer and 10 normal volunteers;the monocyte-derived dendritic cells were generated in vitro using GM-CSF and IL-4.The phenotypes and functions of DCs derived from healthy volunteers and cancer patients were compared using immunofluorescence,FCT,mixed-lymphocyte reaction,FITC-dextran capture,ELISA,and chemotaxis activity of T lymphocytes.Results:DCs derived from cancer patients expressed higher level of PD-L1 at the early stage of the in vitro culture,but lower levels of PD-L2,CCR7 and CXCR4 compared with those derived from healthy volunteers.DCs derived from cancer patients secreted high level of IL-10 and had a retarded ability to stimulate T cells proliferation and to enrich T cells,especially activated T cells,compared with DCs derived from healthy volunteers.Conclusion:High expression of PD-L1 and autocrine of IL-10 may impair the function of DCs derived from cancer patients.
What problem does this paper attempt to address?